Research project

Cragg - Bioinvent - Optimising antibody mediated target cell deletion (Feb 16)

  • Lead researchers:
  • Research funder:
    BioInvent International AB
  • Status:
    Not active

Staff

Lead researchers

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Research outputs